Moreover, a recent study showed that ALKBH5-mediated m 6A demethylation of GLUT4 mRNA promoted drug resistance to HER2-targeted therapy [112]representing a potential therapeutic target for HER2-positive breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.